Disease category | Number of cases diagnosed | Incidence per 100,000 | Mean age at diagnosis | Median age at diagnosis | Range of age |
---|---|---|---|---|---|
Lysosomal Storage Diseases (LSD) | 41 | 37 | 3.6 year | 3 years | 2 months–13 years |
Sphingolipidosis | 22 | 20 | 3.1 years | 2 years | 2 months–13 years |
Fabry disease | 3 | ||||
Sandhoff disease | 2 | ||||
Niemann–Pick disease type B | 1 | ||||
Niemann–Pick disease type C | 3 | ||||
GM1 gangliosidosis (infantile phenotype) | 4 | ||||
Metachromatic leukodystrophy | 3 | ||||
Saposin B Deficiency | 2 | ||||
Krabbe disease | 1 | ||||
Mucopolysaccharidosis (MPS) | 15 | 14 | 5 years | 5 years | 5 months–12 years |
MPS I | 1 | ||||
MPS II | 1 | ||||
MPS IIIA | 2 | ||||
MPS IVA | 5 | ||||
MPS VI | 6 | ||||
Oligosaccharidosis | 2 | 2 | 3 years | 3 years | 2–4 years |
Mucolipidosis II | 1 | ||||
α-mannosidosis | 1 | ||||
Others | |||||
Neuronal ceroid-lipofuscinoses | 3: 2 type 6, and 1 type 8 | 5.3 | 5 | 5–6 years | |
GSD II | 2 | 3.1 months | 3.1 months | 1 week to 6 months | |
Glycogen storage diseases (GSD) | 5 | 4 | 2.2 years | 2 years | 15 months–4 years |
GSD III | 1 | ||||
GSD IV | 1 | ||||
GSD IX | 3 | ||||
Mitochondrial disorders | 12 | 11 | 2.2 years | 8 months | 1 week–8 years |
Leigh disease | 3 | ||||
Pyruvate dehydrogenase deficiency | 2 | ||||
Pyruvate carboxylase deficiency | 2 | ||||
Mitochondrial DNA depletion syndrome 3 | 1 | ||||
Mitochondrial DNA depletion syndrome 5 | 1 | ||||
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 | 1 | ||||
3-Methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like | 1 | ||||
Primary Coenzyme Q10 deficiency type 5 | 1 | ||||
Peroxisomal disorders | 7 | 6 | 2 years | 9 months | 1 week–8 years |
Primary hyperoxaluria type 1 | 5 | ||||
Zellweger syndrome | 1 | ||||
Rhizomelic Chondrodysplasia Punctata | 1 | ||||
Congenital disorders of glycosylation (CDG) | 1 (CDG 1 L) | 1 | 8 years | 8 years | 8 years |
Total | 66 | 60 | 3.1 years | 2 years | 1 week–13 years |